Trial Profile
comparison of rosuvastatin alone versus ezetimib plus standard statin on lipid-lowering effects in patients with dyslipidemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Ezetimibe; Fluvastatin; Pravastatin; Simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 30 Nov 2009 New trial record